Ginkgo Bioworks Holdings, Inc.’s DNA share price has surged by 11.48%, which has investors questioning if this is right time ...

Ginkgo Bioworks Holdings, Inc. (DNA ... And the beauty of RSI is that it helps you quickly and easily check if a stock's ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

TD Cowen analyst Brendan Smith lowered the firm’s price target on Ginkgo Bioworks (DNA ... for investment opportunities with TipRanks’ Stock Screener. Published first on TheFly – the ...

Ginkgo Bioworks missed Q4 revenue estimates and issued ... The company’s valuation is low, but declining revenues and high stock-based compensation pose risks. When I last looked at the stock ...

Now Ginkgo Bioworks is throwing some space in ... which includes laying off workers. The company’s stock price traded as high as $618 in October 2021 but has fallen hard since, trading below ...

Ginkgo Bioworks (DNA) reported its Q4 2024 earnings with a notable increase in cell engineering revenue but faced a significant stock price decline in aftermarket trading. According to InvestingPro ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...

Ginkgo Bioworks (DNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.